Association of endothelial nitric oxide synthase gene polymorphisms with end-stage renal disease: A systematic review and meta-analysis

Renal Failure

Volumn 36, Issue 6, 2014, Pages 987-993

  Yun, Zhu ^a   Yu Ping, Yang ^a   Zong Wu, Tong ^a   Yang, Sun ^a   Fang, Yang ^a   Fang, Sun ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

End stage renal disease; Endothelial nitric oxide synthase; Gene polymorphism; Meta analysis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; MOLECULAR MARKER;

ALLELE; DISEASE COURSE; END STAGE RENAL DISEASE; ENOS GENE; GENE; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; CHRONIC KIDNEY FAILURE; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 84903271031     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.900601     Document Type: Review

References (44)

1. Sowjanya B, Sreenivasulu U, Naidu JN, Sivaranjani N. End stage renal disease, differential diagnosis, a rare genetic disorder: Bardet- Biedl syndrome: case report and review. Indian J Clin Biochem. 2011;26(2):214-216.
2. Kuo CC, Lee CT, Ho SC, Kuo HW, Wu TN, Yang CY. Hemodialysis and the risk of stroke: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Nephrology (Carlton). 2012;17(3):243-248.
3. Halen NV, Cukor D, Constantiner M, Kimmel PL. Depression and mortality in end-stage renal disease. Curr Psychiatry Rep. 2012; 14(1):36-44.
4. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16(12):3736-3741.
5. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;169(4):342-350.
6. Zhou TB, Yin SS. Association of endothelial nitric oxide synthase Glu298Asp gene polymorphism with the risk of end-stage renal disease. Ren Fail. 2013;35(4):573-578.
7. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524-526.
8. Stuehr DJ. Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol. 1997;37:339-359.
9. Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268(23):17478-17488.
10. Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829-837, 837a-837d.
11. Nakayama M, Yasue H, Yoshimura M, et al. T-786!C mutation in the 50-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999; 99(22):2864-2870.
12. Lamblin N, Cuilleret FJ, Helbecque N, et al. A common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions. BMC Cardiovasc Disord. 2005;5:27.
13. Wang XL, Mahaney MC, Sim AS, et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol. 1997; 17(11):3147-3153.
14. Suzuki H, Nagase S, Kikuchi S, Wang Y, Koyama A. Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease. Clin Chem. 2000; 46(11):1858-1860.
15. Walker D, Consugar M, Slezak J, et al. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1. Am J Kidney Dis. 2003;41(1):90-94.
16. Tang FY, Liu FY, Xie XW. Association of angiotensin-converting enzyme and endothelial nitric oxide synthase gene polymorphisms with vascular disease in ESRD patients in a Chinese population. Mol Cell Biochem. 2008;319(1-2):33-39.
17. Lin S, Qu H, Qu M, Yang X. Association of ecNOS4b/a polymorphism and end-stage chronic renal failure. Chin J Internal Med. 2002;41:513-516.
18. Marson BP, Dickel S, Ishizawa MH, et al. Endothelial nitric oxide genotypes and haplotypes are not associated with end-stage renal disease. DNA Cell Biol. 2011;30(1):55-59.
19. Bellini MH, Figueira MN, Piccoli MF, et al. Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology (Carlton). 2007; 12(3):289-293.
20. Kerkeni M, Letaief A, Achour A, Miled A, Trivin F, Maaroufi K. Endothelial nitric oxide synthetase, methylenetetrahydrofolate reductase polymorphisms, and cardiovascular complications in Tunisian patients with nondiabetic renal disease. Clin Biochem. 2009;42(10-11):958-964.
21. Tripathi G, Sharma RK, Baburaj VP, Sankhwar SN, Jafar T, Agrawal S. Genetic risk factors for renal failure among north Indian ESRD patients. Clin Biochem. 2008;41(7-8):525-531.
22. Thaha M, Pranawa, Yogiantoro M, et al. Association of endothelial nitric oxide synthase Glu298Asp polymorphism with end-stage renal disease. Clin Nephrol. 2008;70(2):144-154.
23. Nagase S, Suzuki H, Wang Y, et al. Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem. 2003;244(1-2):113-118.
24. Noiri E, Satoh H, Taguchi J, et al. Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension. 2002; 40(4):535-540.
25. Asakimori Y, Yorioka N, Taniguchi Y, et al. T(-786)!C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron. 2002; 91(4):747-751.
26. Asakimori Y, Yorioka N, Yamamoto I, et al. Endothelial nitric oxide synthase intron 4 polymorphism influences the progression of renal disease. Nephron. 2001;89(2):219-223.
27. Buraczynska M, Ksiazek P, Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant. 2004;19(9):2302-2306.
28. Lamnissou K, Zirogiannis P, Trygonis S, et al. Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus. Genet Test. 2004; 8(3):319-324.
29. El-Din Bessa SS, Hamdy SM. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients. Ren Fail. 2011; 33(9):878-884.
30. de Prado A, Donate T, Martinez E, et al. Endothelial nitric oxide synthase gene polymorphism in dialysis patients. Adv Perit Dial. 2002;18:18-20.
31. Zsom M, Fulop T, Zsom L, Barath A, Maroti Z, Endreffy E. Genetic polymorphisms and the risk of progressive renal failure in elderly Hungarian patients. Hemodial Int. 2011;15(4):501-508.
32. Ulrich C, Heine GH, Seibert E, Fliser D, Girndt M. Circulating monocyte subpopulations with high expression of angiotensinconverting enzyme predict mortality in patients with end-stage renal disease. Nephrol Dial Transplant. 2010;25(7):2265-2272.
33. Sharma R, Agrawal S, Saxena A, Pandey M, Sharma RK. Association of genetic variants of ghrelin, leptin and UCP2 with malnutrition inflammation syndrome and survival in end-stage renal disease patients. Genes Nutr. 2013;8(6):611-621.
34. Kajimoto H, Kai H, Aoki H, et al. Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. Kidney Int. 2012;81(8):762-768.
35. Jensen FB. The role of nitrite in nitric oxide homeostasis: a comparative perspective. Biochim Biophys Acta. 2009;1787(7): 841-848.
36. Figueroa XF, Lillo MA, Gaete PS, Riquelme MA, Saez JC. Diffusion of nitric oxide across cell membranes of the vascular wall requires specific connexin-based channels. Neuropharmacology. 2013;75:471-478.
37. Umar S, van der Laarse A. Nitric oxide and nitric oxide synthase isoforms in the normal, hypertrophic, and failing heart. Mol Cell Biochem. 2010;333(1-2):191-201.
38. Song J, Yoon Y, Park KU, et al. Genotype-specific influence on nitric oxide synthase gene expression, protein concentrations, and enzyme activity in cultured human endothelial cells. Clin Chem. 2003;49(6 Pt 1):847-852.
39. Tsukada T, Yokoyama K, Arai T, et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun. 1998;245(1):190-193.
40. Andersen ML, Guindalini C, Santos-Silva R, Bittencourt LR, Tufik S. Association analysis of endothelial nitric oxide synthase G894T gene polymorphism and erectile dysfunction complaints in a population-based survey. J Sex Med. 2010;7(3):1229-1236.
41. Joshi MS, Mineo C, Shaul PW, Bauer JA. Biochemical consequences of the NOS3 Glu298Asp variation in human endothelium: altered caveolar localization and impaired response to shear. FASEB J. 2007;21(11):2655-2663.
42. Su MT, Lin SH, Chen YC. Genetic association studies of angiogenesis- and vasoconstriction-related genes in women with recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(6):803-812.
43. Yu CK, Casas JP, Savvidou MD, Sahemey MK, Nicolaides KH, Hingorani AD. Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) and development of pre-eclampsia: a case-control study and a meta-analysis. BMC Pregnancy Childbirth. 2006;6:7.
44. Nakayama M, Yasue H, Yoshimura M, et al. T(-786)! C mutation in the 50-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol. 2000; 86(6):628-634.